About

Intro

Management Team Executive Advisors Scientific Advisory Board Contact Us

Newly Diagnosed Stargardt Disease Dry AMD Dry Eye Disease Proliferative Vitreoretinopathy (PVR)

REV-0100 Dry Eye Disease Therapy PVR Therapy

Investor Overview Press Releases

About Company Management Team Executive Advisors Scientific Advisory Board Contact Us Patients Newly Diagnosed Stargardt Disease Dry AMD Dry Eye Disease Proliferative Vitreoretinopathy (PVR) Pipeline REV-0100 Dry Eye Disease Therapy PVR Therapy Investors Investor Overview Press Releases

Intro

Our Executive Advisors

Kathryn Gregory, MBA

Executive Advisor & Chief Business Officer

Houman David Hemmati, MD, Ph.D.

Medical Advisor

Nine rectangles show nine eyes of people of different eye colors, races, and ages.

Terms Of Service Privacy Policy Contact Us

© reVision Therapeutics, Inc., 2024.